DR info

Clinical trial : 0 / Drug : 0 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0

Aromatic L-amino acid decarboxylase deficiency and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
323	Aromatic L-amino acid decarboxylase deficiency
6	Parkinson disease
21	Mitochondrial disease
13	Multiple sclerosis/Neuromyelitis optica
2	Amyotrophic lateral sclerosis
17	Multiple system atrophy
34	Neurofibromatosis
46	Malignant rheumatoid arthritis
65	Primary immunodeficiency
96	Crohn disease
280	Huge arteriovenous malformation with cervicofacial or limb lesion
90	Retinitis pigmentosa
8	Huntington disease
5	Progressive supranuclear palsy
113	Muscular dystrophy
78	Hypopituitarism
107	Juvenile idiopathic arthritis
206	Fragile X syndrome
226	Interstitial cystitis with Hunners ulcer
11	Myasthenia gravis
22	Moyamoya disease
70	Spinal stenosis
215	Tetralogy of Fallot
118	Myelomeningocele
288	Autoimmune acquired coagulation factor deficiency
169	Menkes disease
170	Occipital horn syndrome
4	Primary lateral sclerosis
254	Porphyria
212	Tricuspid atresia